Fig. 1 · Structure

Documents & Downloads

CHS-828 (GMX1778)

Cat. No. A12515 CAS 200484-11-3

NAMPT inhibitor

CHS-828 is a potent inhibitor of NAD+ biosynthesis enzyme NAMPT with IC50 <25 nM.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

CHS-828 is a potent inhibitor of NAD+ biosynthesis enzyme NAMPT with IC50 <25 nM.

Target & Activity

Target Activity Value
NAMPT 25 nM
NAMPT Kd 120 nM

Cellular Effect

Cell Line Activity Value Description Reference
A2780 IC50 0.001 μM Inhibition of NAMPT in human A2780 cells assessed as decrease in cell viability after 72 hrs by SRB assay [PMID: 27541271]
A2780 IC50 0.005 μM Cytotoxicity against human A2780 cells after 72 hrs by SRB assay [PMID: 23617784]
A2780 IC50 0.005 μM Antiproliferative activity against human A2780 cells after 72 hrs by sulforhodamine B assay [PMID: 24405419]
A2780 IC50 0.005 μM Antiproliferative activity against human A2780 cells assessed as growth inhibition after 72 hrs by SRB-based microplate reader analysis [PMID: 23859118]
A2780 IC50 0.56 nM Cytotoxicity against human A2780 cells assessed as growth inhibition after 72 hrs by WST-1 assay [PMID: 24164086]
DLD-1 IC50 2315 nM Cytotoxicity against human DLD1 cells after 24 hrs by SRB assay [PMID: 25147148]
DLD-1 IC50 2315 nM Anticancer activity against human DLD-1 cells assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
HA22T cell line IC50 2067 nM Cytotoxicity against human HA22T cells after 24 hrs by SRB assay [PMID: 25147148]
HA22T cell line IC50 2067 nM Anticancer activity against human HA22T cells assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
HepG2 IC50 1245 nM Cytotoxicity against human HepG2 cells after 24 hrs by SRB assay [PMID: 25147148]
HepG2 IC50 1245 nM Anticancer activity against human HepG2 cells assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
HepG2 IC50 18.3 nM Inhibition of NAMPT in human HepG2 cells using [14C]-nicotinamide/PRPP as substrate assessed as formation of [14C]-nicotinamide mononucleotide after 1 hr by liquid scintillation counting analysis [PMID: 24164086]
HONE1 cell line IC50 15 nM Cytotoxicity against human HONE1 cells after 24 hrs by SRB assay [PMID: 25147148]
HONE1 cell line IC50 15 nM Anticancer activity against human HONE1 cell line assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
MCF7 IC50 1.6 nM Cytotoxicity against human MCF-7 cells assessed as growth inhibition after 72 hrs by WST-1 assay [PMID: 24164086]
MCF7 IC50 18 nM Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
NUGC IC50 25 nM Cytotoxicity against human NUGC cells after 24 hrs by SRB assay [PMID: 25147148]
NUGC IC50 25 nM Anticancer activity against human NUGC cells assessed as cell growth inhibition incubated for 24 hrs [PMID: 35694689]
PC-3 IC50 4.4 nM Antiproliferative activity against human PC3 cells assessed as reduction in cell viability incubated for 5 days by Cell-titer Glo reagent based assay [PMID: 28610984]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 200484-11-3
Applications NAMPT inhibitor
Formula C19H22ClN5O
Molecular Weight 371.86
Synonyms GMX1778
SMILES
ClC1=CC=C(OCCCCCC/N=C(\N=C2C=CNC=C/2)NC#N)C=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 64 mg/mL (172.1 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...